Managing Erosive Esophagitis in the Primary Care Setting
Wednesday, April 17, 2024
12:15 PM – 1:15 PM ET simulcast
11:15 AM – 12:15 PM CT
10:15 AM – 11:15 AM MT
9:15 AM – 10:15 AM PT
Program Features:
- Interactive, case-based learning environment
- Downloadable animation
- Create your own Personalized Poster
Program Overview
This live activity is designed with the goal of increasing participants’ knowledge of current and emerging therapeutic options for erosive esophagitis; improving their understanding of clinical trial data on novel therapeutic options for erosive esophagitis; and helping them to encourage safe and effective management of patients with erosive esophagitis together with the multidisciplinary care team.
Target Audience
This activity is designed to meet the educational needs of primary care and internal medicine physicians and their clinical teams, including nurse practitioners, physician assistants, and pharmacists.
Learning Objectives
Upon the completion of this program, attendees should be able to:
- Compare the mechanisms of action of current and novel emerging therapeutic options for the treatment of patients with erosive esophagitis
- Interpret clinical trial data on novel therapeutic options for erosive esophagitis
- Facilitate the safe and effective management of patients with erosive esophagitis through participation in multidisciplinary care teams
Joint Accreditation Statement
Physician Credit Designation Statement
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
Nurses (ANCC) Credit Designation
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure Of Unlabeled Use
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (ie, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com
Release date: April 17, 2024
Expiration date: April 17, 2024
Estimated time to completion: 1.0 hour
